Abstract: The present invention relates to a compound of the formula (I), (II) or (III), to the use of the compound in an electronic device, and to an electronic device comprising a compound of the formula (I), (II) or (III). The present invention furthermore relates to a process for the preparation of a compound of the formula (I), (II) or (III) and to a formulation comprising one or more compounds of the formula (I), (II) or (III).
Type:
Grant
Filed:
August 14, 2017
Date of Patent:
September 14, 2021
Assignee:
Merck Patent GmbH
Inventors:
Amir Hossain Parham, Arne Buesing, Christof Pflumm, Teresa Mujica-Fernaud, Philipp Stoessel, Thomas Eberle, Frank Voges
Abstract: The invention relates to polycondensed lactam compounds as materials for use in electronic devices, and electronic devices, in particular organic electroluminescent devices, containing said materials.
Type:
Grant
Filed:
June 3, 2014
Date of Patent:
September 14, 2021
Assignee:
Merck Patent GmbH
Inventors:
Amir Hossain Parham, Christof Pflumm, Thomas Eberle, Anja Jatsch, Elvira Montenegro, Jonas Valentin Kroeber, Rouven Linge
Abstract: The present invention refers to a crystalline salt comprising 5-methyl-(6S)-tetrahydrofolic acid and an amino acid ethyl ester like L-phenylalanine ethyl ester or L-methionine ethyl ester, wherein the molar ratio of 5-methyl-(6S)-tetrahydrofolic acid to amino acid ethyl ester is from 1:0.3 to 1:3.0 (in mol/mol) and/or hydrates and/or solvates thereof as well as to a process of obtaining the same.
Type:
Application
Filed:
July 2, 2019
Publication date:
September 9, 2021
Applicant:
MERCK PATENT GMBH
Inventors:
Rudolf MOSER, Viola GROEHN, Ruth BOEHNI STAMM, Fritz BLATTER, Martin SZELAGIEWICZ
Abstract: The invention relates to a liquid-crystalline medium which comprises at least one compound of the formula I, in which R1, R1*, rings A and B, Z1, L1, L2, a and b have the meanings indicated in Claim 1, and to the use thereof for an active-matrix display, in particular based on the VA, PSA, PS-VA, PALC, FFS, PS-FFS, IPS or PS-IPS effect.
Type:
Application
Filed:
May 7, 2021
Publication date:
September 9, 2021
Applicant:
Merck Patent GmbH
Inventors:
Melanie KLASEN-MEMMER, Achim GOETZ, Georg BERNATZ
Abstract: The present invention relates to a liquid-crystal medium which comprises one or more compounds each of formulae I and II in which the occurring groups and parameters have the meanings given in claim 1.
Abstract: The present invention refers to a crystalline salt comprising 5-methyl-(6S)-tetrahydrofolic acid and L-valine ethyl ester wherein the molar ratio of 5-methyl-(6S)-tetrahydrofolic acid and L-valine ethyl ester is from 1:0.3 to 1:3.0 (in mol/mol) and/or hydrates and/or solvates thereof as well as to a process of obtaining the same.
Type:
Application
Filed:
July 2, 2019
Publication date:
September 9, 2021
Applicant:
Merck Patent GmbH
Inventors:
Rudolf MOSER, Viola GROEHN, Ruth BOEHNI STAMM, Fritz BLATTER, Martin SZELAGIEWICZ
Abstract: The present invention relates to novel compounds, particularly to hydrophilic compounds, comprising a photoactive unit, said novel compounds being particularly suitable for ophthalmic devices. The present application also relates to ophthalmic devices comprising such compounds.
Type:
Grant
Filed:
May 7, 2020
Date of Patent:
September 7, 2021
Assignee:
Merck Patent GmbH
Inventors:
Lars Dobelmann-Mara, Stefan Riedmueller, Martin Schraub
Abstract: A switchable optical element and method for detecting breakage of a substrate (A, B) of at least one switchable optical element (10) having a first substrate (A) and a second substrate (B), the first substrate (A) being coated with a first electrode and the second substrate (B) being coated with a second electrode, and a switchable layer (14), the switchable layer (14) being sandwiched between the first substrate (A) and second substrate (B), the first electrode and second electrode each having at least one contact, by i) measuring a change in a differential signal measured at two contacts of a substrate (A, B), ii) measuring a change in capacitance between the two substrates (A, B), iii) measuring a change in resistance of at least one of the substrates (A, B), iv) measuring a change in current applied to the switchable optical element (10).
Abstract: The present invention relates to the field of tracing and anti-counterfeit protection of physical objects, and particularly to preparing and performing a secure authentication of such objects. Specifically, the invention is directed to a method and a system for preparing a subsequent secured authentication of a physical object or group of physical objects by a recipient thereof, to a method and system for authenticating a physical object or group of physical objects, to a method and system of securely providing a time-variant combination scheme for authenticating a physical object or group of physical objects according to the above methods, and to related computer programs corresponding to said methods. The invention is based on the concept of increasing the security level by increasing the information entropy of the data on which the anti-counterfeit protection is based by means of random data communicated to authenticating entities in an algorithmically hidden way.
Type:
Grant
Filed:
January 30, 2020
Date of Patent:
September 7, 2021
Assignee:
Merck Patent GmbH
Inventors:
Thomas Endress, Daniel Szabo, Frederic Berkermann, Natali Melgarejo Diaz
Abstract: The present invention is directed to a crystalline salt of 5-methyl-(6S)-tetrahydrofolic acid and L-isoleucine ethyl ester wherein the molar ratio of 5-methyl-(6S)-tetrahydrofolic acid to L-isoleucine ethyl ester is from 1:0.3 to 1:2.0 (in mol/mol) and/or hydrates and/or solvates thereof, as well as, a process of obtaining the same.
Type:
Application
Filed:
July 2, 2019
Publication date:
September 2, 2021
Applicant:
Merck Patent GmbH
Inventors:
Rudolf MOSER, Viola GROEHN, Ruth BOEHNI STAMM, Fritz BLATTER, Martin SZELAGIEWICZ
Abstract: A crystalline form of (S)-[2-chloro-4-fluoro-5-(7-morpholin-4-yl-quinazolin-4-yl)-phenyl]-(6-methoxy-pyridazin-3-yl)-methanol can be prepared as a pharmaceutical composition.
Type:
Grant
Filed:
March 28, 2018
Date of Patent:
August 31, 2021
Assignee:
Merck Patent GmbH
Inventors:
Michael Lange, Clemens Kuehn, Thomas Fuchss, David Maillard, Marcel Breuning, Marco Poma, Edoardo Burini
Abstract: The present invention relates to aromatic compounds suitable for preparation of asymmetric polydentate ligands. The present invention further describes a process for preparing asymmetric polydentate ligands and metal complexes comprising these ligands which are suitable for use as emitters in organic electroluminescent devices.
Abstract: The present invention relates to compounds which are suitable for use in electronic devices, and to electronic devices, in particular organic electroluminescent devices, comprising these compounds.
Abstract: Methods, compositions, and medical kits are useful for treating and preventing multiple sclerosis using 1-(4-(((6-amino-5-(4-phenoxyphenyl)pyrimidin-4-yl)amino)methyl)piperidin-1-yl)prop-2-en-1-one, or a pharmaceutically acceptable salt thereof, according to preferred dosing regimens.
Type:
Application
Filed:
July 19, 2019
Publication date:
August 26, 2021
Applicant:
Merck Patent GmbH
Inventors:
Martin Dyroff, David Mitchell, Orestis Papasouliotis
Abstract: The present invention relates to a gravure printing process for the production of a virtual three-dimensional pattern in a coating comprising flake-form effect pigments on a print substrate, to a coating produced in this way, and to the use thereof.
Type:
Application
Filed:
June 17, 2019
Publication date:
August 26, 2021
Applicant:
MERCK PATENT GMBH
Inventors:
Johannes TASCH, Ruediger SMOLKA, Peter CLAUTER, Klaus-Christian ULLMANN
Abstract: A solid form of 1-(4-{[6-Amino-5-(4-phenoxy-phenyl)-pyrimidin-4-ylamino]-methy}-4-fluoro-piperidin-1-yl)-propenone, or pharmaceutically acceptable salts thereof, is useful as a BTK inhibitor.
Type:
Application
Filed:
June 17, 2019
Publication date:
August 26, 2021
Applicant:
Merck Patent GmbH
Inventors:
Michael LANGE, Clemens Kuehn, Tobias Schlueter, Werner Mederski, David Maillard, Edoardo Burini
Abstract: The invention relates to liquid-crystal mixtures which comprise polyfluorinated additives, and to liquid-crystal displays based on these mixtures.
Type:
Application
Filed:
June 4, 2019
Publication date:
August 26, 2021
Applicant:
Merck Patent GmbH
Inventors:
In-Young CHO, Yong-Jun JI, Eun-Kyu LEE, Hye-Ryung PARK
Abstract: Fluorene derivatives that are connected in one or more of the 1-, 1?-, 4-, or 4?-positions in any combination to a carbon atom of a diaryl substituted triazinyl or pyrimidinyl derivative. The fluorene derivatives are not spirobifluorene derivatives. The compounds are suitable for use in electronic devices, in particular organic electroluminescent devices, comprising these compounds. In some embodiments, the compounds are used as matrix materials for phosphorescent or fluorescent emitters as well as a hole-blocking or an electron-transport layer.
Type:
Grant
Filed:
July 1, 2016
Date of Patent:
August 24, 2021
Assignee:
Merck Patent GmbH
Inventors:
Anja Jatsch, Amir Hossain Parham, Thomas Eberle, Tobias Grossmann, Jonas Valentin Kroeber
Abstract: The present invention relates to organic semiconducting compounds of formula (I) wherein X1 is C, Si or Ge; X2 is 0, S or Se; and X3 is N or P as well as to organic electronic devices comprising such organic semiconducting compounds.
Type:
Grant
Filed:
August 8, 2017
Date of Patent:
August 24, 2021
Assignee:
Merck Patent GmbH
Inventors:
Daniel Becker, Andreas Taugerbeck, Martin Schraub